Groundbreaking Nipah Virus Vaccine Enters Human Trials: A Beacon of Hope

SUMMARY

AI Generated Content
  • Vaccine uses measles virus for immunity.
  • Trial aims to confirm safety and efficacy.
  • Nipah virus has 40-75% fatality rate.
AD
AD